NASDAQ: DYN · Health Care / Biotechnology: Pharmaceutical Preparations

Dyne Therapeutics Inc.

How Dyne Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$3.2B

Price

$17.04

P/E

-5.4

EPS (TTM)

$-3.14

1-year return

-27.9%

Dividend yield

0.0%

52-week range

$14.25–$20.12

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources